$HIMS stock can 100X from here.

Operating as a telehealth company, $Hims & Hers Health (HIMS.US)$ connects patients with physicians through an app and automates medication fulfillment via its proprietary pharmacy facilities.

Here are the six key drivers influencing the company's growth:
1. Cost Advantage: $Hims & Hers Health (HIMS.US)$ provides treatments for a growing number of conditions at prices lower than typical insurance-covered costs. This cost efficiency creates a strong competitive moat in an industry plagued by rising expenses.
2. Vertical Expansion: $HIMS is consistently broadening its scope, wisely selecting new verticals, which is reflected in its increasing cash flows each quarter.
3. Exceptional Organizational Skills: $HIMS has built an operation from the ground up, integrating software (app) and hardware (pharmacies) within the complex healthcare sector. Its iOS app, ranked #16 in US healthcare just two years after launch, showcases this organizational excellence.
4. AI-Driven Insights: $HIMS leads with the world’s first AI closed loop in healthcare, uniquely using data-derived insights to continuously improve healthcare infrastructure. This positions $HIMS for faster growth compared to its peers.
5. Personalization: By expanding the range of treated conditions, $HIMS aims to lower Customer Acquisition Cost (CAC) and increase Customer Lifetime Value (LTV) through personalized treatments. This enhances $HIMS' indispensability to customers, promoting longer engagement with the platform.
6. Operating Leverage: As $HIMS expands its verticals and optimizes its automated pharmacy operations, its personalized services become harder to replicate at scale. This should lead to improved unit economics over time, as reflected in its strengthening cash flow profile 👇